Cusatuzumab (ARGX-110) is a human CD70 monoclonal antibody with enhanced antibody-dependent cytotoxic activity that blocks CD70/CD27 signaling and targets CD70-expressing LSCs, eliminating LSCs in vitro and in xenograft assays.
Purity:
95.00%
CAS Number:
[1864871-20-4]
Target:
Apoptosis|||Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted